SMAD4 and neoplasm: This may indicate a role for delivery of HCQ especially to patients with SMAD4 loss in order to improve tumor resectability and inform patient selection for future studies on HCQ or other emergent and experimental autophagy inhibitors.32, 33, 34, 35, 36